News & Updates
Filter by Specialty:
COVID-19 in childhood cancer patients: What are the risk factors?
A large international database study has shown that children and adolescents with cancer have an elevated risk of severe or critical disease if infected with COVID-19. Furthermore, about half the patients receiving cancer therapy experienced modifications to their treatment regimens.
COVID-19 in childhood cancer patients: What are the risk factors?
04 Oct 2021Singapore lags in latent tuberculosis screening among HIV-positive individuals
Latent tuberculosis (TB) infection screening in Singapore, a nation with intermediate TB burden, appears to be below average among individuals who are HIV-positive, a study has revealed.
Singapore lags in latent tuberculosis screening among HIV-positive individuals
04 Oct 2021Childhood URTI, antibiotic exposure up susceptibility to atopic, allergic diseases in young adulthood
Individuals who had been exposed to upper respiratory tract infection (URTI) and antibiotics as a child are at heightened risks of atopic dermatitis and allergic skin diseases in their young adulthood, as reported in a study.
Childhood URTI, antibiotic exposure up susceptibility to atopic, allergic diseases in young adulthood
02 Oct 2021COVID-19 vacc side effects: Fewer than expected?
A community-based study from the UK showed that the rate of systemic side effects is relatively low following vaccination with the BNT162b2 or ChAdOx1 nCoV-19 COVID-19 vaccines.
COVID-19 vacc side effects: Fewer than expected?
01 Oct 2021Lung ultrasound boosts accuracy of pneumonia diagnosis in ED
Lung ultrasound proves to be a useful tool for screening community-acquired pneumonia in the emergency department (ED), with a recent study showing that its use brings down diagnostic uncertainty from 73 percent to 14 percent.
Lung ultrasound boosts accuracy of pneumonia diagnosis in ED
30 Sep 2021Casirivimab-imdevimab combo may reduce hospitalization in mild-to-moderate COVID-19
Treatment with a combination of the recombinant human IgG1 monoclonal antibodies casirivimab and imdevimab reduced hospitalization rates in high-risk patients with mild-to-moderate COVID-19, according to results of a retrospective study.
Casirivimab-imdevimab combo may reduce hospitalization in mild-to-moderate COVID-19
29 Sep 2021Inhaled JAK inhibitor cuts exhaled nitric oxide in mild asthma
GDC-0214, an inhaled Janus kinase (JAK) inhibitor, induces dose-dependent reductions in fractional exhaled nitric oxide in patients with mild asthma, a recent study has found.